R

Active Director Director DIN 10189583
DIN 10189583 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Rajrani

Data last updated:

Rajrani is a Director at Aquadrugs Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Aquadrugs Pharmaceuticals Private Limited reported revenue of ₹1.58 Cr (FY 2025).

DIN 10189583
Primary Designation Director
Industry Pharma
First Appointment 02 Jun 2023
Oldest Company Age 3 yrs
Largest company Aquadrugs Pharmaceuticals Private Limited · ₹1.58 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jun 20232023₹1.58 Cr (FY 2025)Active

Board colleagues of Rajrani

Directorship timeline

Open interactive timeline →
Aquadrugs Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajrani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajrani

Rajrani currently holds 1 directorship: Aquadrugs Pharmaceuticals Private Limited (Director, since 02 Jun 2023, revenue ₹1.58 Cr (FY 2025)).

Rajrani was first appointed on 02 Jun 2023 as Director at Aquadrugs Pharmaceuticals Private Limited.

The current boards of Rajrani's companies include Girdhari Lal (Aquadrugs Pharmaceuticals Private Limited), Gourav Kumar (Aquadrugs Pharmaceuticals Private Limited), Pabitra Pradhan (Aquadrugs Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available